CG Bio, a Korean generative medicine developer, said Friday that it participated in the Aesthetic & Anti-Aging Medicine World Congress (AMWC) 2024 in Monaco from March 27 to 29, showcasing its aesthetic total solution products.

AMWC is the world's largest plastic surgery and aesthetic clinic congress, held annually in Monte Carlo. This year, more than 120 countries from Europe, Asia, South America, and the Middle East participated in the event, which attracted more than 10,000 dermatologists, plastic surgeons, and aesthetic industry professionals to discover the latest anti-aging products and technologies.

CG Bio ran a booth at the event, showcasing its flagship products LUXX, Easy Dew EGF Skin Booster, PLA Tone Skin Booster, the calcium hydroxyapatite (CaHA) filler Facetem, and the hyaluronic acid (HA) filler Aileene, the company said.

"The high level of interest in suture LUXX and next-generation skin boosters confirms that our products can fill an unmet market need," said CG Bio CEO Yu Hyun-seung. "We will continue to innovate and secure a leading position in the global aesthetic surgery field.